EBITDA for Humana (HUM)
According to Humana's latest reported financial statements, the company's current EBITDA (TTM) is $2.91B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
HUM
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$2.91B
YoY change
-10.7%
5Y CAGR
-12.2%
Peak year (2020)
$5.57B
Cumulative EBITDA
$36.30B
EBITDA history chart for Humana (HUM) from 1990 to 2025
EBITDA history table for Humana (HUM) from 1990 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $2.91B | -10.7% | ||
| 2024 | $3.25B | -31.2% | ||
| 2023 | $4.73B | -1.7% | ||
| 2022 | $4.81B | +7.9% | ||
| 2021 | $4.46B | -20.0% | ||
| 2020 | $5.57B | +30.0% | ||
| 2019 | $4.29B | +51.7% | ||
| 2018 | $2.83B | -401.9% | ||
| 2017 | -$936.00M | — | ||
| 2016 | $0 | -100.0% | ||
| 2015 | -$270.00M | — | ||
| 2014 | $0 | — | ||
| 2013 | $0 | -100.0% | ||
| 2012 | $46.00M | — | ||
| 2011 | $0 | -100.0% | ||
| 2010 | $162.40M | — | ||
| 2009 | $0 | -100.0% | ||
| 2008 | $103.10M | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | -100.0% | ||
| 2005 | $461.03M | -15.6% | ||
| 2004 | $546.31M | +13.7% | ||
| 2003 | $480.36M | +40.6% | ||
| 2002 | $341.53M | -10.0% | ||
| 2001 | $379.40M | +28.1% | ||
| 2000 | $296.22M | -221.2% | ||
| 1999 | -$244.48M | -164.7% | ||
| 1998 | $378.06M | +195.4% | ||
| 1997 | $128.00M | +17.4% | ||
| 1996 | $109.00M | +34.6% | ||
| 1995 | $81.00M | -75.6% | ||
| 1994 | $332.00M | +514.8% | ||
| 1993 | $54.00M | -82.5% | ||
| 1992 | $309.00M | -12.5% | ||
| 1991 | $353.00M | +3.2% | ||
| 1990 | $342.20M | — |
EBITDA values are taken from Humana's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Humana (HUM) EBITDA totalled $2.91B – declined 10.7% year-over-year.
Humana EBITDA has contracted on net over the period, with a -12.2% compound annual growth rate over 2020–2025 (5 years).
Humana EBITDA peaked at $5.57B in 2020; the latest annual figure is $2.91B in 2025 (47.8% below peak).
The dataset's maximum EBITDA sits at $5.57B (2020); the minimum reading of -$936.00M dates to 2017.
Humana (HUM) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $24.21B.
Humana EBITDA by Year
Humana EBITDA 2025: $2.91B
Humana EBITDA in 2025 was $2.91B, declined 10.7% below 2024.
Humana EBITDA 2024: $3.25B
Humana EBITDA in 2024 was $3.25B, plunged 31.2% below 2023.
Humana EBITDA 2023: $4.73B
Humana EBITDA in 2023 was $4.73B, edged down 1.7% below 2022.
Humana EBITDA 2022: $4.81B
Humana EBITDA in 2022 was $4.81B, grew 7.9% from 2021.
Humana EBITDA 2021: $4.46B
Humana EBITDA in 2021 was $4.46B.
See more financial history for Humana (HUM).
Sector peers — EBITDA
Companies in the same sector as Humana, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Humana's EBITDA?
- Latest reported EBITDA for Humana (HUM) is $2.91B (period ending December 31, 2025).
How has Humana EBITDA changed year-over-year?
- Humana (HUM) EBITDA changed -10.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Humana EBITDA?
- Humana (HUM) EBITDA compound annual growth rate is -12.2% over the most recent 5 years available.
When did Humana EBITDA hit its highest annual value?
- Humana EBITDA reached its highest annual value of $5.57B in 2020.
What was Humana EBITDA in 2024?
- Humana (HUM) EBITDA in 2024 was $3.25B.
What was Humana EBITDA in 2025?
- Humana (HUM) EBITDA in 2025 was $2.91B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
HUM Overview
Company profile, financial tools, and key metrics
HUM Revenue Counter
Earns $4,112 every second. See per minute, hour, and day.
HUM Earnings Counter
Earns $37.67 per second net profit. See per minute, hour, and day.
HUM Economic Scale
Exceeds Puerto Rico (US)'s GDP. Compare with world economies.
HUM What If Invested
What if you had invested $1,000? See historical returns from any date.
HUM How It Makes Money
Discover visual breakdown of $129.66B in revenue — where it comes from and where it goes.
HUM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
HUM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
HUM Daily Price Character
Balanced · 48.4% historical win rate (green days). Streaks & record days.
HUM Buybacks
0.49% TTM buyback yield. Shareholder yield & SBC comparison.
HUM Stock Split History
8 splits on record. Dates, ratios, and cumulative multiple.
HUM Dividend Profile
Yield: 1.46%. Safety: 3/8. See full history.
HUM Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
HUM Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.